Business

FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study

FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study

articleSyntara LimitedNovember 8, 20213/company/syntara-limited/news/fda-clears-pxs-cancer-drug-for-phase-2-liver-cancer-study
FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study

About this update from Syntara Limited

[{"type":"text","content":"Syntara Limited has released a press release. View Attachment","length":228,"tagName":"div"}]

More updates from Syntara Limited